Air monitoring
Measure and predict COVID-19 risk in commercial and public buildings
Oct 01 2020
Ambisense have announced its entry into the air quality market with the launch of AmbiAir, a solution designed to help manage, assess, and predict the COVID-19 risk in commercial and public buildings.
‘As a company we’re always looking to use our technological expertise to develop solutions for pressing geo-environmental problems. This led us to create AmbiAir, a product designed to help keep people as safe as possible in these trying times, and as a compliment to established approaches such as social distancing.’ stated Stephen McNulty, Ambisense’s founder and CEO.
By increasing building ventilation, and combining it with measures such as social distancing, we can decrease the COVID-19 risk that we face in public spaces. Studies show that the danger of exposure to COVID-19 is reduced when the level of CO2 is below 600ppm, relative humidity is between 40-60%, and there are no or very minimal levels of PM2.5.
AmbiAir is a low-cost solution that combines discreet, multi-deployable hardware with Ambilytics, an intelligent platform that digs through the vast quantities of location-based data to quickly and easily understand the performance of the critical risk drivers, identifying risk hot-spots in real-time, and predicting when safe levels are likely to be breached.
The first in a range of air quality solutions being released this year, AmbiAir combines multiple tools and techniques useful to air quality professionals to understand the behaviour of air quality pollutants.
Digital Edition
AET 28.4 Oct/Nov 2024
November 2024
Gas Detection - Go from lagging to leading: why investment in gas detection makes sense Air Monitoring - Swirl and vortex meters will aid green hydrogen production - Beyond the Stack: Emi...
View all digital editions
Events
Jan 12 2025 Abu Dhabi, UAE
Jan 14 2025 Abu Dhabi, UAE
Jan 20 2025 San Diego, CA, USA
Carrefour des Gestions Locales de L'eau
Jan 22 2025 Rennes, France
Safety, Health & Wellbeing LIVE
Jan 22 2025 Manchester, UK